Estimating implant survival in the presence of competing risks

International Orthopaedics

Volumn 35, Issue 2, 2011, Pages 151-155

  Biau, David J ^a   Hamadouche, Moussa ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; HUMAN; IMPLANT; INCIDENCE; KAPLAN MEIER METHOD; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL TIME;

DATA INTERPRETATION, STATISTICAL; EQUIPMENT FAILURE ANALYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; REOPERATION; RISK ASSESSMENT; RISK FACTORS;

EID: 79955930514     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-010-1097-2     Document Type: Review

References (17)

1. Bernoulli D (1760) Essai d'une nouvelle analyse de la mortalité causée par la petite vérole, et des avantages de l'inoculation pour la prévenir. Mémoires de l'académie Royale des Sciences Paris, pp 1-45
2. Biau D, Faure F, Katsahian S, Jeanrot C, Tomeno B, Anract P (2006) Survival of total knee replacement with a megaprosthesis after bone tumor resection. J Bone Joint Surg Am 88:1285-1293 (Pubitemid 43837123)
3. Biau DJ, Latouche A, Porcher R (2007) Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate? Clin Orthop Relat Res 462:229-233
4. Biau DJ, Davis A, Vastel L, Tomeno B, Anract P (2008) Function, disability, and health-related quality of life after allograftprosthesis composite reconstructions of the proximal femur. J Surg Oncol 97:210-215 (Pubitemid 351312158)
5. Biau DJ, Larousserie F, Thévenin F, Piperno-Neumann S, Anract P (2009) Results of 32 allograft-prosthesis composite reconstructions of the proximal femur. Clin Orthop Relat Res 468:834-845
6. Biau DJ, Thévenin F, Dumaine V, Babinet A, Tomeno B, Anract P (2009) Ipsilateral femoral autograft reconstruction after resection of a pelvic tumor. J Bone Joint Surg Am 91:142-151
7. Cox RD (1972) Regression models and life tables (with discussion). J Roy Stat Soc B 74:187-220
8. Dobbs HS (1980) Survivorship of total hip replacements. J Bone Joint Surg Br 62:168-173
9. Falez F, Favetti F, Casella F, Panegrossi G (2008) Hip resurfacing: why does it fail? Early results and critical analysis of our first 60 cases. Int Orthop 32:209-216 (Pubitemid 351422681)
10. Fennema P, Lubsen J (2010) Survival analysis in total joint replacement. An alternative method of accounting for the presence of competing risk. J Bone Joint Surg Br 92:701-706
11. Fine JP, Gray RJ (1999) A proportional hazard model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509
12. Fuchs B, Hoekzema N, Larson DR, Inwards CY, Sim FH (2009) Osteosarcoma of the pelvis outcome analysis of surgical treatment. Clin Orthop Relat Res 467:510-518
13. Hamadouche M, Boutin P, Daussange J, Bolander ME, Sedel L (2002) Alumina on alumina total hip arthroplasty. A minimal 18.5 -year follow-up study. J Bone Joint Surg Am 84:69-77
14. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:448-457
15. Prentice RL, Kalbfleisch JD, Peterson AVJ, Flournoy N, Farewell VT, Breslow NE (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541-554 (Pubitemid 9067879)
16. Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 26:2389-2430 (Pubitemid 46730255)
17. Wangen H, Lereim P, Holm I, Gunderson R, Reikeras O (2008) Hip arthroplasty in patients younger than 30 years: excellent ten to 16-year follow-up results with a HA-coated stem. Int Orthop 32:203-208 (Pubitemid 351422678)